00513nas a2200169   4500000000100000008004100001100005000042700001800092700001400110700001600124700001500140700001800155700001500173245013600188300001200324490000700336       2001                            d1 aADVANCE Collaborative Group Writing Committee1 aFerrannini E.1 aGirgis S.1 aChalmers J.1 aNeal Bruce1 aPatel Anushka1 aMacmahon S00aStudy rationale and design of ADVANCE: action in diabetes and vascular disease – Preterax and Diamicron MR  Controlled Evaluation  a1118-200 v44